Oncology Department

The Oncology Department (Medical Oncology) of Tianjin First Central Hospital is a young department. It was established in September 2022. It currently has a total of 33 beds open. General outpatient clinics and specialist outpatient clinics are opened in Fukang Road Campus and Shuixi Campus to meet the medical needs of the majority of cancer patients to the greatest extent. The Department of Medical Oncology currently has 9 doctors (5 with Master of Medicine and 4 with Doctor of Medicine), with a reasonable talent gradient, including 1 chief physician, 1 deputy chief physician, 4 attending physicians, 3 residents, and 15 people in the nursing department. Zhao Zhigang is currently the leader of the Department of Medical Oncology, a doctoral supervisor, chief physician, and a distinguished professor in Tianjin. He currently serves as a member of the Standing Committee of the Cancer Rehabilitation Professional Committee of the Chinese Association of Rehabilitation Medicine, a member of the Hematology Tumors Special Committee of the Tianjin Anti-Cancer Association, a member of the Lymphoma Special Committee of the Tianjin Anti-Cancer Association, a member of the Geriatric Tumor Special Committee of the Tianjin Anti-Cancer Association, and a member of the Hematology Special Committee of the Tianjin Society of Integrated Traditional Chinese and Western Medicine. He has profound knowledge in targeted therapy and personalized treatment of malignant tumors, tumor epigenetic regulation and stem cell biology, and is a well-known expert in this field in China.The department mainly treats a variety of solid tumors, such as lung cancer, breast cancer, esophageal cancer, gastric cancer, pancreatic cancer, liver cancer, cholangiocarcinoma, colorectal cancer, ovarian cancer, etc., as well as a variety of hematological malignant diseases, such as lymphoma, multiple myeloma, and leukemia. Under the leadership of Director Zhao Zhigang, the medical staff of the oncology department will tailor diagnosis and treatment plans for cancer patients, thereby providing professional, precise, systematic, individualized and full-scale, all-round "one-stop" diagnostic services to maximize the survival time of patients and improve their quality of life.